Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,984,612 papers from all fields of science
Search
Sign In
Create Free Account
vincristine liposome
Known as:
Vincacine
, Vincristine Liposomal
, Liposomal Vincristine
Expand
A liposomal formulation of Vincristine designed to reduce toxicity and improve efficacy. Vincristine binds irreversibly to microtubules and spindle…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (2)
Marqibo
Vincristine sulfate liposome
Microtubule Process
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Liposomal Vincristine as a Bridge Therapy Prior to CAR-T Therapy in Relapsed and Refractory Diffuse Large B-Cell Lymphoma?
J. Chadha
,
Shafinaz Hussein
,
+4 authors
A. Steinberg
International Journal of Hematology-Oncology and…
2019
Corpus ID: 149603473
We report a case of a 76-year-old male with a history of relapsed and refractory diffuse large B-cell lymphoma (DLBCL).Our…
Expand
2015
2015
Phase II study of hyper-CMAD with liposomal vincristine as frontline therapy for patients with acute lymphoblastic leukemia
K. Sasaki
,
S. O'brien
,
+12 authors
E. Jabbour
2015
Corpus ID: 74751497
2014
2014
Pharmacokinetics of liposomal-encapsulated and un-encapsulated vincristine after injection of liposomal vincristine sulfate in beagle dogs
J. Zhong
,
Wenxue Mao
,
+5 authors
Yueming Ma
Cancer Chemotherapy and Pharmacology
2014
Corpus ID: 21191386
AbstractPurposeVincristine sulfate (VCR) is a potent and widely used anti-tumor drug. Encapsulating VCR with liposomes improves…
Expand
2013
2013
Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer
Jennifer I. Hare
,
E. Moase
,
T. Allen
Journal of drug targeting (Print)
2013
Corpus ID: 23312994
Purpose: We used two ligand-modified liposomal drugs to selectively deliver two different chemotherapeutics to tumor cells (TC…
Expand
2011
2011
[Preparation and in vitro release characteristics of vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles].
Rong Tan
,
Y. Liu
,
Nianping Feng
,
Jihui Zhao
Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
2011
Corpus ID: 13546296
OBJECTIVE To prepare vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles (VCR-PBCA-NPs) and to investigate the in…
Expand
2009
2009
[Therapeutic effect and toxicity of compound vincristine liposome on breast cancer in nude mice].
Tong Chen
,
S. Hou
,
Yong-yan Wang
,
Wen-sheng Zhang
,
Hui Liao
Sheng wu yi xue gong cheng xue za zhi = Journal…
2009
Corpus ID: 30529170
This study was intended to assess the therapeutic effect and toxicity of Compound vincristine liposome on breast cancer in nude…
Expand
2006
2006
Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity
S. Shan
,
C. Flowers
,
+6 authors
M. Dewhirst
Cancer Chemotherapy and Pharmacology
2006
Corpus ID: 2136339
To quantitatively evaluate the extravasation, accumulation and selectivity to tumor tissues of liposomal vincristine (LV), dorsal…
Expand
Review
2004
Review
2004
Vincristine liposomal--INEX: lipid-encapsulated vincristine, onco TCS, transmembrane carrier system--vincristine, vincacine, vincristine sulfate liposomes for injection, VSLI.
Drugs in R&D
2004
Corpus ID: 32246539
INEX Pharmaceuticals is developing a liposomal formulation of vincristine [Onco TCS, vincacine, VSLI, Vincristine sulfate…
Expand
2001
2001
Drug-Drug Interactions Arising From the Use of Liposomal Vincristine in Combination with Other Anticancer Drugs
D. Waterhouse
,
N. Santos
,
L. Mayer
,
M. Bally
Pharmaceutical Research
2001
Corpus ID: 29837515
Chemotherapeutic agents for cancer treatment typically are given as combination therapies from multiple classes of drugs (1–4…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE